Company · CIK 1790340
Immuneering Corp
| CIK | 1790340 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | IMRX (Nasdaq) |
| First annual or quarterly report | 2021-09-09 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-289589 | 2025-08-13 | 2025-09-25 | 4 | |
| 333-289997 | 2025-09-03 | 2025-09-08 | 2 | |
| 333-266738 | 2022-08-10 | 2025-06-23 | 6 | |
| 333-257791 | 2021-07-09 | 2021-07-30 | 5 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-09-25 | 424B5Shelf takedown | 333-289589 | 0001104659-25-093438 |
| 2025-09-24 | 424B5Shelf takedown | 333-289589 | 0001104659-25-092991 |
| 2025-09-08 | EFFECTDeclared effective | 333-289997 | 9999999995-25-002880 |
| 2025-09-03 | S-3Shelf registered | 333-289997 | 0001104659-25-086561 |
| 2025-08-20 | EFFECTDeclared effective | 333-289589 | 9999999995-25-002696 |
| 2025-08-13 | S-3Shelf registered | 333-289589 | 0001104659-25-077655 |
| 2025-06-23 | 424B5Shelf takedown | 333-266738 | 0001104659-25-061344 |
| 2025-03-20 | 424B5Shelf takedown | 333-266738 | 0001104659-25-026222 |
| 2023-04-19 | 424B5Shelf takedown | 333-266738 | 0001104659-23-047187 |
| 2023-04-18 | 424B5Shelf takedown | 333-266738 | 0001104659-23-046468 |
| 2022-08-19 | EFFECTDeclared effective | 333-266738 | 9999999995-22-002454 |
| 2022-08-10 | S-3Shelf registered | 333-266738 | 0001104659-22-088662 |
| 2021-07-30 | 424B4Final prospectus | 333-257791 | 0001104659-21-098251 |
| 2021-07-29 | EFFECTDeclared effective | 333-257791 | 9999999995-21-002979 |
| 2021-07-28 | S-1/AAmendment | 333-257791 | 0001104659-21-096615 |
| 2021-07-26 | S-1/AAmendment | 333-257791 | 0001104659-21-095557 |
| 2021-07-09 | S-1Registration filed | 333-257791 | 0001104659-21-090635 |
| 2021-05-13 | DRSDraft made public | 377-04858 | 0001104659-21-065999 |